Skip to menu Skip to content Skip to footer
Professor Phillip Good
Professor

Phillip Good

Email: 

Overview

Availability

Professor Phillip Good is:
Available for supervision

Works

Search Professor Phillip Good’s works on UQ eSpace

152 works between 2001 and 2024

1 - 20 of 152 works

2024

Conference Publication

A study into the benefit of ‘standard palliative care’ on symptom control in randomised controlled trials

Weerasinghe, Aanjanee Dodanwela, Gurgenci, Taylan, Hardy, Janet and Good, Phillip (2024). A study into the benefit of ‘standard palliative care’ on symptom control in randomised controlled trials. ANZSPM 2024 Biennial Conference, Adelaide, SA Australia, 5 - 8 September 2024. London, United Kingdom: BMJ Group. doi: 10.1136/spcare-2024-anzspm.19

A study into the benefit of ‘standard palliative care’ on symptom control in randomised controlled trials

2024

Conference Publication

Clinical studies of medicinal cannabis in palliative care – The development of a research program

Good, Phillip, Foster, Karyn, Greer, Ristan, Pelecanos, Anita, Huggett, Georgie, Kearney, Alison, Gurgenci, Taylan and Hardy, Janet (2024). Clinical studies of medicinal cannabis in palliative care – The development of a research program. ANZSPM 2024 Biennial Conference, Adelaide, SA, United States, 5-8 September 2024. London, United Kingdom: BMJ Group. doi: 10.1136/spcare-2024-anzspm.63

Clinical studies of medicinal cannabis in palliative care – The development of a research program

2024

Conference Publication

Genomic variation in symptom expression in men with castrate resistant prostate cancer

Good, Phillip, Foster, Karyn, Greer, Ristan, Oliveira, Niara, Vayne-Bossert, Petra, Ewing, Adam and Hardy, Janet (2024). Genomic variation in symptom expression in men with castrate resistant prostate cancer. ANZSPM 2024 Biennial Conference, Adelaide, SA, United States, 5-8 September 2024. London, United Kingdom: BMJ Group. doi: 10.1136/spcare-2024-anzspm.61

Genomic variation in symptom expression in men with castrate resistant prostate cancer

2024

Journal Article

Drug dependence epidemiology in palliative care medicinal cannabis trials

Lee, Chee Yen, Good, Phillip, Huggett, Georgie, Greer, Ristan and Hardy, Janet (2024). Drug dependence epidemiology in palliative care medicinal cannabis trials. BMJ Supportive and Palliative Care, 14 (3), 295-298. doi: 10.1136/spcare-2023-004583

Drug dependence epidemiology in palliative care medicinal cannabis trials

2024

Conference Publication

OP-42 Incidence and outcomes of falls in an inpatient palliative care unit: a single-centre retrospective study

Stack, Paul, Fischer, Amanda and Good, Phillip (2024). OP-42 Incidence and outcomes of falls in an inpatient palliative care unit: a single-centre retrospective study. British Medical Journal Publishing Group. doi: 10.1136/spcare-2024-anzspm.42

OP-42 Incidence and outcomes of falls in an inpatient palliative care unit: a single-centre retrospective study

2024

Conference Publication

OP-33 Constructing a queensland palliative care research teletrial network

Stokes, Claire, Gurgenci, Taylan, Poxton, Melanie and Good, Phillip (2024). OP-33 Constructing a queensland palliative care research teletrial network. British Medical Journal Publishing Group. doi: 10.1136/spcare-2024-anzspm.33

OP-33 Constructing a queensland palliative care research teletrial network

2024

Conference Publication

P-14 Drug interactions in people on cannabidiol – is there cause for concern?

Downs, Georgia, Greer, Ristan, Moses, Geraldine, Gurgenci, Taylan, Good, Phillip and Hardy, Janet (2024). P-14 Drug interactions in people on cannabidiol – is there cause for concern?. British Medical Journal Publishing Group. doi: 10.1136/spcare-2024-anzspm.62

P-14 Drug interactions in people on cannabidiol – is there cause for concern?

2024

Conference Publication

OP-11 A double-blind randomised controlled trial of dose-escalated CBD/THC oil for symptom management in advanced cancer

Good, Phillip, Greer, Ristan, Pelecanos, Anita, Kearney, Alison, Huggett, Georgie, Gurgenci, Taylan and Hardy, Janet (2024). OP-11 A double-blind randomised controlled trial of dose-escalated CBD/THC oil for symptom management in advanced cancer. British Medical Journal Publishing Group. doi: 10.1136/spcare-2024-anzspm.11

OP-11 A double-blind randomised controlled trial of dose-escalated CBD/THC oil for symptom management in advanced cancer

2024

Journal Article

Incidence and outcomes of falls in an inpatient palliative care unit: a single-centre retrospective study

Stack, Paul, Fischer, Amanda and Good, Phillip (2024). Incidence and outcomes of falls in an inpatient palliative care unit: a single-centre retrospective study. BMJ Supportive & Palliative Care, spcare-2024. doi: 10.1136/spcare-2024-005132

Incidence and outcomes of falls in an inpatient palliative care unit: a single-centre retrospective study

2024

Journal Article

Ketamine for cancer pain: re. systematic review by Jiao et al

Bell, Rae Frances, Poon, Peter, Good, Phillip and Andrew Moore, R. (2024). Ketamine for cancer pain: re. systematic review by Jiao et al. Journal of Pain and Symptom Management. doi: 10.1016/j.jpainsymman.2024.08.029

Ketamine for cancer pain: re. systematic review by Jiao et al

2024

Journal Article

Top Ten Tips Palliative Care Clinicians Should Know About Interpreting a Clinical Trial

Gurgenci, Taylan, O’Leary, Cian, Hui, David, Yennu, Sriram, Bruera, Eduardo, Davis, Mellar, Agar, Meera R., Zimmermann, Camilla, Philip, Jennifer, Mercadante, Sebastiano, Hardy, Janet, Rosa, William E. and Good, Phillip (2024). Top Ten Tips Palliative Care Clinicians Should Know About Interpreting a Clinical Trial. Journal of Palliative Medicine. doi: 10.1089/jpm.2024.0258

Top Ten Tips Palliative Care Clinicians Should Know About Interpreting a Clinical Trial

2024

Journal Article

Evidence-based physiotherapy interventions: evaluation of current practice in a palliative care service

Pennycooke, Linda, Cree, Rosalind, Fischer, Amanda and Good, Phillip (2024). Evidence-based physiotherapy interventions: evaluation of current practice in a palliative care service. Progress in Palliative Care, ahead-of-print (ahead-of-print), 1-7. doi: 10.1080/09699260.2024.2374067

Evidence-based physiotherapy interventions: evaluation of current practice in a palliative care service

2024

Book Chapter

Measuring wellbeing: a critical rapid review of scales used in advanced cancer contexts

Smith, Alexandra, Olson, Rebecca, Cuerton, Maddison, Khalil, Keesha Abdul, Good, Phillip and Hardy, Janet (2024). Measuring wellbeing: a critical rapid review of scales used in advanced cancer contexts. Researching Contemporary Wellness Cultures. (pp. 63-79) edited by Naomi Smith, Clare Southerton and Marianne Clark. Leeds, United Kingdom: Emerald Publishing. doi: 10.1108/978-1-80455-584-220241005

Measuring wellbeing: a critical rapid review of scales used in advanced cancer contexts

2024

Journal Article

Psychological distress and physical symptoms in advanced cancer: cross-sectional study

Podbury, Bridget, Gurgenci, Taylan, Huggett, Georgie, Greer, Ristan, Hardy, Janet and Good, Phillip (2024). Psychological distress and physical symptoms in advanced cancer: cross-sectional study. BMJ Supportive & Palliative Care, spcare-2024. doi: 10.1136/spcare-2024-004940

Psychological distress and physical symptoms in advanced cancer: cross-sectional study

2024

Conference Publication

A randomized, double-blind controlled trial of medicinal cannabis vs placebo for symptom management in patients with advanced cancer receiving palliative care

Hardy, Janet Rea, Greer, Ristan, Gurgenci, Taylan, Kearney, Alison, Ladwa, Rahul, Huggett, Georgie and Good, Phillip (2024). A randomized, double-blind controlled trial of medicinal cannabis vs placebo for symptom management in patients with advanced cancer receiving palliative care. 2024 ASCO Annual Meeting, Chicago, IL United States, 31 May - 4 June 2024. Alexandria, VA United States: American Society of Clinical Oncology. doi: 10.1200/JCO.2024.42.16_suppl.12020

A randomized, double-blind controlled trial of medicinal cannabis vs placebo for symptom management in patients with advanced cancer receiving palliative care

2024

Journal Article

Medicinal Cannabis (MedCan 3): a randomised, multicentre, double-blind, placebo-controlled trial to assess THC/CBD (1:20) to relieve symptom burden in patients with cancer—a study protocol for a randomised controlled trial

Gurgenci, Taylan, Hardy, Janet, Huggett, Georgie, Foster, Karyn, Pelecanos, Anita, Greer, Ristan, Philip, Jennifer, Haywood, Alison, Mendis, Ruwani, Yates, Patsy and Good, Phillip (2024). Medicinal Cannabis (MedCan 3): a randomised, multicentre, double-blind, placebo-controlled trial to assess THC/CBD (1:20) to relieve symptom burden in patients with cancer—a study protocol for a randomised controlled trial. Trials, 25 (1) 293. doi: 10.1186/s13063-024-08091-z

Medicinal Cannabis (MedCan 3): a randomised, multicentre, double-blind, placebo-controlled trial to assess THC/CBD (1:20) to relieve symptom burden in patients with cancer—a study protocol for a randomised controlled trial

2024

Journal Article

Preliminary results from a Phase IV surveillance study of medical cannabis use in Australian patients with advanced cancer receiving palliative care

Gurgenci, Taylan, Hardy, Janet, Good, Christopher and Good, Phillip (2024). Preliminary results from a Phase IV surveillance study of medical cannabis use in Australian patients with advanced cancer receiving palliative care. Journal of Palliative Medicine, 27 (5), 663-666. doi: 10.1089/jpm.2023.0358

Preliminary results from a Phase IV surveillance study of medical cannabis use in Australian patients with advanced cancer receiving palliative care

2024

Journal Article

Impact of the COVID-19 pandemic on the use of an inpatient and community palliative care service

Doo, Irene, Fischer, Amanda, Griffin, Alison and Good, Phillip (2024). Impact of the COVID-19 pandemic on the use of an inpatient and community palliative care service. International Journal of Palliative Nursing, 30 (3), 138-145. doi: 10.12968/ijpn.2024.30.3.138

Impact of the COVID-19 pandemic on the use of an inpatient and community palliative care service

2024

Journal Article

The effects of OPRM1 118A>G on methadone response in pain management in advanced cancer at end of life

Haupt, Larisa M., Haywood, Alison, Sutherland, Heidi G., Yu, Chieh, Albury, Cassie L., Pharasi, Anushka, Zunk, Mathew, George, Rani, Griffiths, Lyn R., Good, Phillip and Hardy, Janet (2024). The effects of OPRM1 118A>G on methadone response in pain management in advanced cancer at end of life. Scientific Reports, 14 (1) 3411, 1-9. doi: 10.1038/s41598-024-54009-9

The effects of OPRM1 118A>G on methadone response in pain management in advanced cancer at end of life

2024

Journal Article

Cannabinol oil or placebo in advanced cancer–disease progression and survival: a secondary analysis

O’Leary, Cian, Greer, Ristan, Huggett, Georgie, Good, Phillip, Gurgenci, Taylan and Hardy, Janet (2024). Cannabinol oil or placebo in advanced cancer–disease progression and survival: a secondary analysis. BMJ Supportive and Palliative Care, 14 (2), 191-194. doi: 10.1136/spcare-2023-004746

Cannabinol oil or placebo in advanced cancer–disease progression and survival: a secondary analysis

Funding

Current funding

  • 2024 - 2027
    Developing a Queensland Palliative Care Research Tele-trial Program
    Queensland Health Clinical Research Fellowships
    Open grant
  • 2021 - 2025
    Medicinal Cannabis (MedCan 3) - randomised, multicentre, double blind, placebo-controlled trial to assess THC/CBD (1:20) to relieve symptom burden in patients with cancer
    NHMRC MRFF EPCDR Medicinal Cannabis
    Open grant
  • 2020 - 2024
    An international, double-blind, dose increment, parallel-arm, randomised controlled trial of duloxetine versus pregabalin for opioid... (NHMRC CTCS administered by University Technology Sydney)
    University of Technology Sydney
    Open grant

Past funding

  • 2018 - 2023
    Medicinal cannabinoids to relieve symptom burden in the palliative care of patients with advanced cancer
    NHMRC MRFF - Lifting Clinical Trials Registries Capacity
    Open grant
  • 2017 - 2020
    Talking about death: A study into palliative care communication
    Mater Misericordiae Ltd
    Open grant

Supervision

Availability

Professor Phillip Good is:
Available for supervision

Before you email them, read our advice on how to contact a supervisor.

Supervision history

Current supervision

  • Doctor Philosophy

    Evidence based use of oral medicinal cannabinoids in the palliative management of patients with advanced cancer

    Principal Advisor

    Other advisors: Associate Professor Rebecca Olson

  • Doctor Philosophy

    Development, implementation and evaluation of a Queensland palliative care research teletrial platform to explore the benefits of medicinal cannabis in advanced cancer

    Principal Advisor

    Other advisors: Dr Anthony Herbert

  • Doctor Philosophy

    Discursive Renderings of Medicinal Cannabis Patients: Policy, Practice, Priorities

    Associate Advisor

    Other advisors: Dr Jenny Munro, Associate Professor Rebecca Olson

Media

Enquiries

For media enquiries about Professor Phillip Good's areas of expertise, story ideas and help finding experts, contact our Media team:

communications@uq.edu.au